Trials / Conditions / Renal Cell Carcinoma, Clear Cell
Renal Cell Carcinoma, Clear Cell
4 registered clinical trials studyying Renal Cell Carcinoma, Clear Cell — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-lin NCT06708949 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma NCT06656039 | RenJi Hospital | — |
| Completed | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizum NCT05585034 | Xencor, Inc. | Phase 1 |
| Unknown | Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma NCT03280667 | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Phase 2 |